Alessandra Anna Prete

Monitoring PD-L1 positive circulating tumor cells in non-small cell lung cancer patients treated with the PD-1 inhibitor Nivolumab

Chiara Nicolazzo, Cristina Raimondi, M. Mancini et al. · Scientific Reports · 2016 · 271 citations · Full text

Medicine, Immunology, Oncology +17

Prediction of Benefit from Checkpoint Inhibitors in Mismatch Repair Deficient Metastatic Colorectal Cancer: Role of Tumor Infiltrating Lymphocytes

Fotios Loupakis, Ilaria Depetris, Paola Biason et al. · The Oncologist · 2020 · 112 citations · Full text

Medicine, Immunology, Oncology +17

The Pan-Immune-Inflammation Value in microsatellite instability–high metastatic colorectal cancer patients treated with immune checkpoint inhibitors

Francesca Corti, Sara Lonardi, Rossana Intini et al. · European Journal of Cancer · 2021 · 109 citations

Medicine, Immunology, Oncology +14

A validated prognostic classifier for BRAF-mutated metastatic colorectal cancer: the ‘BRAF BeCool’ study

Fotios Loupakis, Rossana Intini, Chiara Cremolini et al. · European Journal of Cancer · 2019 · 70 citations · Full text

Medicine, Oncology, Pathology +16

Randomized phase II trial of avelumab alone or in combination with cetuximab for patients with previously treated, locally advanced, or metastatic squamous cell anal carcinoma: the CARACAS study

Sara Lonardi, Alessandra Anna Prete, Federica Morano et al. · Journal for ImmunoTherapy of Cancer · 2021 · 47 citations · Full text

Medicine, Oncology, Pharmacology +17